Sisram Medical Ltd
SRAMF
$0.5512
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 90.19M | 90.19M | 84.37M | 84.37M | 93.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 90.19M | 90.19M | 84.37M | 84.37M | 93.84M |
| Cost of Revenue | 34.51M | 34.51M | 31.71M | 31.71M | 36.72M |
| Gross Profit | 55.68M | 55.68M | 52.66M | 52.66M | 57.11M |
| SG&A Expenses | 42.78M | 42.78M | 39.77M | 39.77M | 42.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2.39M | 2.39M | 1.60M | 1.60M | 1.37M |
| Total Operating Expenses | 83.61M | 83.61M | 77.11M | 77.11M | 85.31M |
| Operating Income | 6.59M | 6.59M | 7.25M | 7.25M | 8.53M |
| Income Before Tax | 8.91M | 8.91M | 7.36M | 7.36M | 8.20M |
| Income Tax Expenses | 1.13M | 1.13M | 760.50K | 760.50K | 1.14M |
| Earnings from Continuing Operations | 7.78M | 7.78M | 6.60M | 6.60M | 7.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -695.00K | -695.00K | -1.13M | -1.13M | -757.50K |
| Net Income | 7.09M | 7.09M | 5.48M | 5.48M | 6.30M |
| EBIT | 6.59M | 6.59M | 7.25M | 7.25M | 8.53M |
| EBITDA | 9.40M | 9.40M | 10.06M | 10.06M | 11.28M |
| EPS Basic | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 468.34M | 468.34M | 468.34M | 468.34M | 467.43M |
| Average Diluted Shares Outstanding | 468.34M | 468.34M | 468.34M | 468.34M | 467.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 66.67% | 66.67% | -- | -- | 83.41% |